Systemic therapy alters the landscape of surgery in hepatocellular carcinoma： opportunities and challenges
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 2
Abstract
Surgery is still the first choice for patients with hepatocellular carcinoma(HCC). However, about 70% of HCC patients in China are first diagnosed in the advanced stage and have lost the opportunity for surgery. Recently, the rapid development of systematic therapy has brought new hope for patients with advanced HCC. The combination of molecular targeted therapy and immunotherapy with or without local therapy significantly improves the survival of advanced HCC and alters the landscape of surgical treatment in advanced HCC. In addition, systemic therapy also brings new opportunities for perioperative treatment of HCC patients. Conversion therapy, neoadjuvant therapy, and postoperative adjuvant therapy can increase the chances of surgical treatment, reduce the risk of postoperative metastasis and recurrence, and prolong the overall survival of HCC patients. Systematic therapy based on molecular targeted therapy and immunotherapy has been applied through the whole process of HCC surgical treatment, and has completely altered the surgery paradigm of HCC. However, further research is needed to determine the optimal combination protocol, screen the sensitive populations, address drug resistance, and reduce systemic adverse events.
Authors and Affiliations
Weiqing SHAO, Lu LU, Lunxiu QIN
Keywords
Related Articles
- EP ID EP750961
- DOI 10.16139/j.1007-9610.2024.02.01
- Views 38
- Downloads 1
Prospects for updates on the field of liver surgery in “Guidelines for Diagnosis and Treatment of Primary Hepatocellular Carcinoma in China (2019 Edition)”
Precision surgery in diagnosis and treatment of hepatocellular carcinoma
Current status of high-positioned digestive tract reconstruction after laparoscopic proximal stomach and lower esophagus resection through the abdominal-left diaphragmatic approach for adenocarcinoma of esophagogastric junction
In recent years, the rising incidence of adenocarcinoma of esophagogastric junction (AEG) and the subsequent surge in early detections have transformed the surgical treatment of AEG into a topic of substantial interest....
Diagnostic application of SpyGlass in indeterminate stricture of hilar bile duct
[Objective:] To investigate the diagnostic value of SpyGlass choledochoscopy system in indeterminate stricture of hilar bile duct. [Methods:] A retrospective analysis was conducted on 146 patients with indeterminate stri...
Update of pathology in medullary thyroid carcinoma
Medullary thyroid carcinoma (MTC) is a rare thyroid malignancy, which is more aggressive with high metastasis and recurrence rate. Surgical treatment is the preferred treatment option for MTC. Targeted therapy and immuno...